Additionally, CRC cell fluorescence-activated cell sorting (FACS) analysis identified the CD44+ cell subgroup as possessing high clonogenicity and in vivo tumorigenicity (Chu et al., 2009). This evidence concerns the gene CD44 and colorectal carcinoma.